Entero Healthcare Solutions Ltd

Entero Healthcar Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Entero Healthcare Solutions Ltd

₹ 1,316 1.15%
21 Feb - close price
enterohealthcare.com BSE: 544122 NSE: ENTERO
About

Incorporated in 2018, Entero Healthcare
Solutions Ltd is in the business of distribution
and marketing of pharmaceutical and surgical products and allied services[1]

Key Points

Business Overview:[1]
EHSL, a leading Healthcare Supply Chain Solutions Specialist, ranks among India’s top three healthcare product distributors by revenue, offering demand fulfillment and generation solutions to manufacturers.

Website BSE NSE
  • Market Cap ₹ 5,724 Cr.
  • Current Price ₹ 1,316
  • High / Low ₹ 1,584 / 970
  • Stock P/E 63.5
  • Book Value ₹ 387
  • Dividend Yield 0.00 %
  • ROCE 6.71 %
  • ROE 4.98 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Stock is trading at 3.40 times its book value
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Retail Industry: Trading

Part of Nifty Total Market Nifty Microcap 250 BSE Consumer Discretionary BSE IPO BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
829 887 899 996 993 1,034 1,097 1,301 1,359
810 867 873 968 964 1,005 1,067 1,258 1,309
Operating Profit 19 20 26 29 29 29 30 42 50
OPM % 2% 2% 3% 3% 3% 3% 3% 3% 4%
2 1 1 2 2 9 13 11 8
Interest 13 13 14 18 16 17 10 11 10
Depreciation 5 7 6 6 6 7 7 7 8
Profit before tax 2 1 7 7 8 14 27 35 39
Tax % -44% 490% 6% 23% 16% -56% 25% 25% 25%
4 -4 6 5 7 21 21 26 29
EPS in Rs 8.05 -9.05 15.18 3.19 4.22 4.82 4.62 5.43 5.85
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
1,780 2,522 3,300 3,922 4,791
1,758 2,498 3,236 3,810 4,639
Operating Profit 22 24 64 112 152
OPM % 1% 1% 2% 3% 3%
4 4 6 14 41
Interest 20 29 49 66 48
Depreciation 16 20 24 25 29
Profit before tax -11 -20 -4 36 115
Tax % 42% 49% 201% -12%
-15 -29 -11 40 97
EPS in Rs -1,550.90 -77.71 -28.12 8.99 20.72
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 30%
TTM: 27%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 66%
TTM: 524%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 13%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.10 4 4 43 43
Reserves -32 -62 -73 1,595 1,639
720 974 1,101 338 361
145 210 275 369 609
Total Liabilities 833 1,125 1,308 2,345 2,653
189 262 268 289 554
CWIP 2 1 0 0 0
Investments 0 0 0 0 3
643 863 1,040 2,056 2,096
Total Assets 833 1,125 1,308 2,345 2,653

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024
-69 -35 -45 -37
-31 -162 -49 -704
89 211 73 863
Net Cash Flow -11 14 -21 122

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 50 54 57 57
Inventory Days 54 49 41 43
Days Payable 22 22 25 24
Cash Conversion Cycle 82 81 73 77
Working Capital Days 84 79 72 71
ROCE % 1% 5% 7%

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2024Jun 2024Sep 2024Dec 2024
52.44% 52.44% 52.44% 52.44%
23.30% 23.32% 23.82% 22.20%
2.28% 2.06% 7.73% 8.78%
21.99% 22.18% 16.02% 16.59%
No. of Shareholders 80,86466,40036,76733,172

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls